Company intelligence / Profile preview

Biopharmax

Ownership: Private
Employees: ~117
Development stage: Other

Overview

Biopharmax is an established global provider of end-to-end design, engineering, construction, and validation services for pharmaceutical and biotechnology manufacturing facilities. With over four decades of experience serving industry leaders worldwide—including major projects in Israel and internationally—Biopharmax specializes in turnkey solutions that ensure regulatory compliance (FDA/EMEA/cGMP), cost efficiency, on-time delivery, and technology transfer expertise. They have also launched innovative products such as B-pure for advanced filtration/disinfection systems.

Industry: Contract Manufacturing Organization

Partnerships

Aran Group (for single-use systems packaging via AranBiotech)

Beyond the preview

Go deeper on Biopharmax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biopharmax.

Explore the full profile